Maruho Report 2021

6/58

050753211150020200201902018020170201604（People）Number of female employees / Ratio of female managers (Non-consolidated): As of September 30Maruho strives to provide every employee with opportunities to autonomously grow and play an active role, while establishing a safe and healthy workplace environment. Starting from October 2021, the targets to be achieved by September 2024 are a female manager ratio of more than 15%, zero individuals working over 540 overtime hours a year, and zero departments with over 30 overtime hours worked a month for three consecutive months.700■ Number of female employees　● Ratio of female employees● Ratio of female managers60050044347231.732.44003002001007.48.02016201751553049732.933.534.49.812.213.0201820192020201676,72220162016201699,984137,55469.7 201670,07418,01925.7 7,4249.7 2,272（%）5050（People）201786,902201885,209201714,73117.0 201810,63112.5201720182017108,985145,09672.1 2018110,478143,28677.1201779,96514,40518.0 201878,76013,20316.88,463Overtime work frequency (employees / departments) (Non-consolidated): As of September 3010■ Number of employees who worked over 540 overtime hours a year■ Departments with over 30 overtime hours worked a month for 　 three consecutive months5344034.5302011.8102021002,976201989,171201912,34713.8 201912,7372019120,217142,90884.1 201980,71712,27615.2 202088,954202196,754202012,33313.9 202121,94222.7 2020202114,9022020127,825151,39483.7 2021142,857164,25786.3 202080,84915,16818.8 202187,72412,27314.0 6,318（Departments）102021(Consolidated): As of September 30 (Millions of yen)Net salesNet salesOperating profitOperating profitRatio of operating profit to net sales (%)Profit attributable to owners of parentProfit attributable to owners of parentTotal net assets / Total assetsTotal net assetsTotal assetsEquity-to-asset ratio (%)Pharmaceutical business net sales / R&D expensesPharmaceutical business net salesR&D expensesRatio of R&D expenses to net sales (%)Financial HighlightsNon-financial Highlights